229 related articles for article (PubMed ID: 7683018)
1. Chemistry and mode of action of macrolides.
Mazzei T; Mini E; Novelli A; Periti P
J Antimicrob Chemother; 1993 Mar; 31 Suppl C():1-9. PubMed ID: 7683018
[TBL] [Abstract][Full Text] [Related]
2. Rokitamycin: bacterial resistance to a 16-membered ring macrolide differs from that to 14- and 15-membered ring macrolides.
Braga PC
J Chemother; 2002 Apr; 14(2):115-31. PubMed ID: 12017366
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides.
Hardy DJ; Hensey DM; Beyer JM; Vojtko C; McDonald EJ; Fernandes PB
Antimicrob Agents Chemother; 1988 Nov; 32(11):1710-9. PubMed ID: 3252753
[TBL] [Abstract][Full Text] [Related]
4. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
[TBL] [Abstract][Full Text] [Related]
5. Adverse effects of macrolide antibacterials.
Periti P; Mazzei T; Mini E; Novelli A
Drug Saf; 1993 Nov; 9(5):346-64. PubMed ID: 8280403
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic drug interactions of macrolides.
Periti P; Mazzei T; Mini E; Novelli A
Clin Pharmacokinet; 1992 Aug; 23(2):106-31. PubMed ID: 1511528
[TBL] [Abstract][Full Text] [Related]
7. Review of macrolides and ketolides: focus on respiratory tract infections.
Zhanel GG; Dueck M; Hoban DJ; Vercaigne LM; Embil JM; Gin AS; Karlowsky JA
Drugs; 2001; 61(4):443-98. PubMed ID: 11324679
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro potencies of nine new macrolides.
Fernandes PB; Hardy DJ
Drugs Exp Clin Res; 1988; 14(7):445-51. PubMed ID: 3240705
[TBL] [Abstract][Full Text] [Related]
9. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
Mazzariol A; Koncan R; Vitali LA; Cornaglia G
J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
[TBL] [Abstract][Full Text] [Related]
10. Azalides from azithromycin to new azalide derivatives.
Mutak S
J Antibiot (Tokyo); 2007 Feb; 60(2):85-122. PubMed ID: 17420561
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part I).
Periti P; Mazzei T; Mini E; Novelli A
Clin Pharmacokinet; 1989 Apr; 16(4):193-214. PubMed ID: 2656049
[TBL] [Abstract][Full Text] [Related]
12. 16-membered macrolide antibiotics: a review.
Arsic B; Barber J; Čikoš A; Mladenovic M; Stankovic N; Novak P
Int J Antimicrob Agents; 2018 Mar; 51(3):283-298. PubMed ID: 28668674
[TBL] [Abstract][Full Text] [Related]
13. Macrolides allergy.
Araújo L; Demoly P
Curr Pharm Des; 2008; 14(27):2840-62. PubMed ID: 18991703
[TBL] [Abstract][Full Text] [Related]
14. In-vitro activities of 14-, 15- and 16-membered macrolides against gram-positive cocci.
Hamilton-Miller JM
J Antimicrob Chemother; 1992 Feb; 29(2):141-7. PubMed ID: 1506329
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of spiramycin and other macrolides.
Brisson-Noël A; Trieu-Cuot P; Courvalin P
J Antimicrob Chemother; 1988 Jul; 22 Suppl B():13-23. PubMed ID: 3053566
[TBL] [Abstract][Full Text] [Related]
16. Macrolide antibiotics, drug interactions and microsomal enzymes: implications for veterinary medicine.
Anadón A; Reeve-johnson L
Res Vet Sci; 1999 Jun; 66(3):197-203. PubMed ID: 10333459
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro antimicrobial activity of 3-keto 16-membered macrolides derived from tylosin.
Creemer LC; Toth JE; Kirst HA
J Antibiot (Tokyo); 2002 Apr; 55(4):427-36. PubMed ID: 12061552
[TBL] [Abstract][Full Text] [Related]
18. [Allergy to macrolide antibiotics. Review of the literature].
Demoly P; Benahmed S; Valembois M; Sahla H; Messaad D; Godard P; Michel FB; Bousquet J
Presse Med; 2000 Feb; 29(6):321-6. PubMed ID: 10719452
[TBL] [Abstract][Full Text] [Related]
19. [Antimicrobial activity of macrolides against clinical isolates].
Hoshino K; Iwai Y; Nakamura S; Seto I; Yamaguchi K
Jpn J Antibiot; 1998 Apr; 51(4):249-71. PubMed ID: 9644599
[TBL] [Abstract][Full Text] [Related]
20. Role of an energy-dependent efflux pump in plasmid pNE24-mediated resistance to 14- and 15-membered macrolides in Staphylococcus epidermidis.
Goldman RC; Capobianco JO
Antimicrob Agents Chemother; 1990 Oct; 34(10):1973-80. PubMed ID: 1963291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
